• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖是肠道细菌与饮食相互作用的结果。

Obesity as a consequence of gut bacteria and diet interactions.

作者信息

Kotzampassi Katerina, Giamarellos-Bourboulis Evangelos J, Stavrou George

机构信息

Department of Surgery, Medical School, Aristotle University of Thessaloniki, Thessaloniki 54006, Greece.

Fourth Department of Internal Medicine, University of Athens Medical School, Athens 12462, Greece.

出版信息

ISRN Obes. 2014 Mar 6;2014:651895. doi: 10.1155/2014/651895. eCollection 2014.

DOI:10.1155/2014/651895
PMID:24977101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3963190/
Abstract

Obesity is a major public health concern, caused by a combination of increased consumption of energy-dense foods and reduced physical activity, with contributions from host genetics, environment, and adipose tissue inflammation. In recent years, the gut microbiome has also been found to be implicated and augmented research in mice and humans have attributed to it both the manifestation and/or exacerbation of this major epidemic and vice versa. At the experimental level, analysis of fecal samples revealed a potential link between obesity and alterations in the gut flora (drop in Bacteroidetes and increase in Firmicutes), the specific gut microbiome being associated with the obese phenotype. Conventionally raised mice were found to have over 40% more total body fat compared with those raised under germ-free conditions, while conventionalization of germ-free mice resulted in a significant increase in total body fat. Similarly, the sparse data in humans supports the fact that fat storage is favoured by the presence of the gut microbiota, through a multifaceted mechanism. Efforts to identify new therapeutic strategies to modulate gut microbiota would be of high priority for public health, and to date, probiotics and/or prebiotics seem to be the most effective tools.

摘要

肥胖是一个主要的公共卫生问题,它由能量密集型食物消费增加和身体活动减少共同引起,同时宿主基因、环境和脂肪组织炎症也有一定作用。近年来,肠道微生物群也被发现与之有关,对小鼠和人类的更多研究表明,它与这一重大流行病的表现和/或加剧都有关系,反之亦然。在实验层面,对粪便样本的分析揭示了肥胖与肠道菌群变化(拟杆菌减少和厚壁菌增加)之间的潜在联系,特定的肠道微生物群与肥胖表型相关。研究发现,与在无菌条件下饲养的小鼠相比,传统饲养的小鼠体脂总量多40%以上,而无菌小鼠常规化饲养后,体脂总量显著增加。同样,人类方面的少量数据也支持这样一个事实,即肠道微生物群的存在通过多方面机制有利于脂肪储存。确定调节肠道微生物群的新治疗策略对公共卫生至关重要,迄今为止,益生菌和/或益生元似乎是最有效的工具。

相似文献

1
Obesity as a consequence of gut bacteria and diet interactions.肥胖是肠道细菌与饮食相互作用的结果。
ISRN Obes. 2014 Mar 6;2014:651895. doi: 10.1155/2014/651895. eCollection 2014.
2
Changes seen in gut bacteria content and distribution with obesity: causation or association?肥胖时肠道细菌含量和分布的变化:是因果关系还是关联?
Postgrad Med. 2015;127(8):863-8. doi: 10.1080/00325481.2015.1098519. Epub 2015 Oct 16.
3
saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction leptin-mediated AMPKα/STAT3 signaling in diet-induced obesity.皂苷通过调节肠道微生物群促进产热和米色脂肪细胞重构,从而介导饮食诱导肥胖中的瘦素-AMPKα/STAT3 信号通路。
Theranostics. 2020 Sep 14;10(24):11302-11323. doi: 10.7150/thno.47746. eCollection 2020.
4
Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.微生物失调诱导的肥胖:肠道微生物群在能量代谢稳态中的作用。
Br J Nutr. 2020 May 28;123(10):1127-1137. doi: 10.1017/S0007114520000380. Epub 2020 Feb 3.
5
Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in Dogs of Different Body Conditions.日粮蛋白质与碳水化合物比例对不同身体状况犬只肠道微生物群的影响。
mBio. 2017 Jan 24;8(1):e01703-16. doi: 10.1128/mBio.01703-16.
6
Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.肠道微生物群介导膳食 β-羟基-β-甲基丁酸(HMB)对高脂肪饮食诱导肥胖的保护作用。
FASEB J. 2019 Sep;33(9):10019-10033. doi: 10.1096/fj.201900665RR. Epub 2019 Jun 5.
7
Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.肠道微生物组工程治疗肥胖症:当前理解和进展综述。
Biotechnol J. 2020 Oct;15(10):e2000013. doi: 10.1002/biot.202000013. Epub 2020 Jul 27.
8
An obesity-associated gut microbiome with increased capacity for energy harvest.一种与肥胖相关的肠道微生物群,其能量获取能力增强。
Nature. 2006 Dec 21;444(7122):1027-31. doi: 10.1038/nature05414.
9
Gut microbiome approaches to treat obesity in humans.肠道微生物组治疗人类肥胖的方法。
Appl Microbiol Biotechnol. 2019 Feb;103(3):1081-1094. doi: 10.1007/s00253-018-9570-8. Epub 2018 Dec 16.
10
Gut commensal plays a predominant role in the anti-obesity effects of polysaccharides isolated from .肠道共生菌在 中分离得到的多糖的抗肥胖作用中起主要作用。
Gut. 2019 Feb;68(2):248-262. doi: 10.1136/gutjnl-2017-315458. Epub 2018 Jul 14.

引用本文的文献

1
Metagenomics Analysis of the Microbial Consortium in Samples from Lake Xochimilco, a World Cultural Heritage Site.对世界文化遗产地霍奇米尔科湖样本中微生物群落的宏基因组学分析。
Microorganisms. 2025 Apr 7;13(4):835. doi: 10.3390/microorganisms13040835.
2
In Vitro Fecal Fermentation Patterns of Arabinoxylan from Rice Bran on Fecal Microbiota from Normal-Weight and Overweight/Obese Subjects.来自米糠的阿拉伯木聚糖对正常体重和超重/肥胖受试者粪便微生物群的体外粪便发酵模式。
Nutrients. 2021 Jun 15;13(6):2052. doi: 10.3390/nu13062052.
3
A good start in life is important-perinatal factors dictate early microbiota development and longer term maturation.人生的良好开端很重要——围产期因素决定了早期微生物组的发展和长期的成熟。
FEMS Microbiol Rev. 2020 Nov 24;44(6):763-781. doi: 10.1093/femsre/fuaa030.
4
Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis.唾液乳杆菌 BP121 通过缓解肠道菌群失调来抑制尿毒症毒素(如吲哚硫酸酯和对甲酚硫酸酯),从而预防顺铂诱导的急性肾损伤。
Int J Mol Med. 2020 Apr;45(4):1130-1140. doi: 10.3892/ijmm.2020.4495. Epub 2020 Feb 10.
5
Dietary fat intake and age modulate the composition of the gut microbiota and colonic inflammation in C57BL/6J mice.饮食中的脂肪摄入量和年龄会调节 C57BL/6J 小鼠的肠道微生物群组成和结肠炎症。
BMC Microbiol. 2019 Aug 20;19(1):193. doi: 10.1186/s12866-019-1557-9.
6
Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice.共生元驱动的代谢紊乱改善与饮食诱导肥胖小鼠肠道微生物组的变化有关。
Mol Metab. 2019 Apr;22:96-109. doi: 10.1016/j.molmet.2019.01.012. Epub 2019 Feb 5.
7
Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.肠道微生物群、短链脂肪酸与跨越流行病学转变的肥胖:METS-Microbiome 研究方案。
BMC Public Health. 2018 Aug 6;18(1):978. doi: 10.1186/s12889-018-5879-6.
8
Alterations in the gut bacterial microbiome in fungal Keratitis patients.真菌性角膜炎患者肠道细菌微生物组的改变。
PLoS One. 2018 Jun 22;13(6):e0199640. doi: 10.1371/journal.pone.0199640. eCollection 2018.
9
Gut microbiota-derived short-chain fatty acids and kidney diseases.肠道微生物群衍生的短链脂肪酸与肾脏疾病
Drug Des Devel Ther. 2017 Dec 11;11:3531-3542. doi: 10.2147/DDDT.S150825. eCollection 2017.
10
Gut microbiome production of short-chain fatty acids and obesity in children.儿童肠道微生物组产生的短链脂肪酸与肥胖。
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):621-625. doi: 10.1007/s10096-017-3143-0. Epub 2017 Dec 2.

本文引用的文献

1
Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue.膳食脂肪来源的组成塑造了肠道微生物群落结构,并改变了宿主脂肪组织中的炎症介质。
JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):746-54. doi: 10.1177/0148607113486931. Epub 2013 May 2.
2
Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial.加氏乳杆菌BNR17对超重和肥胖成年人的影响:一项随机双盲临床试验
Korean J Fam Med. 2013 Mar;34(2):80-9. doi: 10.4082/kjfm.2013.34.2.80. Epub 2013 Mar 20.
3
Linking the gut microbiota to human health.将肠道微生物组与人类健康联系起来。
Br J Nutr. 2013 Jan;109 Suppl 2:S21-6. doi: 10.1017/S0007114512005235.
4
Probiotics: Interaction with gut microbiome and antiobesity potential.益生菌:与肠道微生物群的相互作用及抗肥胖潜能。
Nutrition. 2013 Apr;29(4):591-6. doi: 10.1016/j.nut.2012.07.017. Epub 2013 Jan 1.
5
Fecal microbiota transplantation: techniques, applications, and issues.粪便微生物移植:技术、应用和问题。
Gastroenterol Clin North Am. 2012 Dec;41(4):781-803. doi: 10.1016/j.gtc.2012.08.008.
6
Gut microbiota, immune development and function.肠道微生物群、免疫发育和功能。
Pharmacol Res. 2013 Mar;69(1):87-113. doi: 10.1016/j.phrs.2012.09.002. Epub 2012 Sep 16.
7
Probiotics for infectious diseases: more drugs, less dietary supplementation.益生菌治疗感染性疾病:多药少补。
Int J Antimicrob Agents. 2012 Oct;40(4):288-96. doi: 10.1016/j.ijantimicag.2012.06.006. Epub 2012 Aug 2.
8
Microbes and the gut-brain axis.微生物与肠脑轴
Neurogastroenterol Motil. 2012 May;24(5):405-13. doi: 10.1111/j.1365-2982.2012.01906.x. Epub 2012 Mar 8.
9
Early gut colonization and subsequent obesity risk.早期肠道定植与随后的肥胖风险。
Curr Opin Clin Nutr Metab Care. 2012 May;15(3):278-84. doi: 10.1097/MCO.0b013e32835133cb.
10
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.小肠细菌过度生长的患病率:小肠培养与肠易激综合征的关系。
Dig Dis Sci. 2012 May;57(5):1321-9. doi: 10.1007/s10620-012-2033-7. Epub 2012 Jan 20.